174 related articles for article (PubMed ID: 16181146)
1. The molecular basis for the mode of action of bicyclomycin.
Kohn H; Widger W
Curr Drug Targets Infect Disord; 2005 Sep; 5(3):273-95. PubMed ID: 16181146
[TBL] [Abstract][Full Text] [Related]
2. Bicyclomycin and dihydrobicyclomycin inhibition kinetics of Escherichia coli rho-dependent transcription termination factor ATPase activity.
Park HG; Zhang X; Moon HS; Zwiefka A; Cox K; Gaskell SJ; Widger WR; Kohn H
Arch Biochem Biophys; 1995 Nov; 323(2):447-54. PubMed ID: 7487110
[TBL] [Abstract][Full Text] [Related]
3. Structural mechanism of inhibition of the Rho transcription termination factor by the antibiotic bicyclomycin.
Skordalakes E; Brogan AP; Park BS; Kohn H; Berger JM
Structure; 2005 Jan; 13(1):99-109. PubMed ID: 15642265
[TBL] [Abstract][Full Text] [Related]
4. The antibiotic bicyclomycin affects the secondary RNA binding site of Escherichia coli transcription termination factor Rho.
Magyar A; Zhang X; Kohn H; Widger WR
J Biol Chem; 1996 Oct; 271(41):25369-74. PubMed ID: 8810302
[TBL] [Abstract][Full Text] [Related]
5. The bicyclomycin sensitivities of 38 bicyclomycin-resistant mutants of transcription termination protein rho and the location of their mutations support a structural model of rho based on the F(1) ATPase.
Moyse KA; Knight JS; Richardson JP
J Mol Biol; 2000 Sep; 302(3):565-79. PubMed ID: 10986119
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the location of bicyclomycin binding to the Escherichia coli transcription termination factor Rho.
Riba I; Gaskell SJ; Cho H; Widger WR; Kohn H
J Biol Chem; 1998 Dec; 273(51):34033-41. PubMed ID: 9852059
[TBL] [Abstract][Full Text] [Related]
7. 5a-formylbicyclomycin: studies on the bicyclomycin-Rho interaction.
Vincent F; Widger WR; Openshaw M; Gaskell SJ; Kohn H
Biochemistry; 2000 Aug; 39(31):9067-76. PubMed ID: 10924099
[TBL] [Abstract][Full Text] [Related]
8. Effects of bicyclomycin on RNA- and ATP-binding activities of transcription termination factor Rho.
Carrano L; Bucci C; De Pascalis R; Lavitola A; Manna F; Corti E; Bruni CB; Alifano P
Antimicrob Agents Chemother; 1998 Mar; 42(3):571-8. PubMed ID: 9517934
[TBL] [Abstract][Full Text] [Related]
9. Transcription termination factor rho: the site of bicyclomycin inhibition in Escherichia coli.
Zwiefka A; Kohn H; Widger WR
Biochemistry; 1993 Apr; 32(14):3564-70. PubMed ID: 8466900
[TBL] [Abstract][Full Text] [Related]
10. The Mg2+ requirements for rho transcription termination factor: catalysis and bicyclomycin inhibition.
Weber TP; Widger WR; Kohn H
Biochemistry; 2002 Oct; 41(41):12377-83. PubMed ID: 12369827
[TBL] [Abstract][Full Text] [Related]
11. Development of a technique to determine bicyclomycin-rho binding and stoichiometry by isothermal titration calorimetry and mass spectrometry.
Brogan AP; Widger WR; Bensadek D; Riba-Garcia I; Gaskell SJ; Kohn H
J Am Chem Soc; 2005 Mar; 127(8):2741-51. PubMed ID: 15725032
[TBL] [Abstract][Full Text] [Related]
12. C(5)-C(5a)-modified bicyclomycins: synthesis, structure, and biochemical and biological properties.
Vincent F; Srinivasan J; Santillán A; Widger WR; Kohn H
J Org Chem; 2001 Apr; 66(7):2251-64. PubMed ID: 11281764
[TBL] [Abstract][Full Text] [Related]
13. Transcription termination factor Rho is essential for Micrococcus luteus.
Nowatzke WL; Keller E; Koch G; Richardson JP
J Bacteriol; 1997 Aug; 179(16):5238-40. PubMed ID: 9260971
[TBL] [Abstract][Full Text] [Related]
14. Rho transcription factor: symmetry and binding of bicyclomycin.
Vincent F; Openshaw M; Trautwein M; Gaskell SJ; Kohn H; Widger WR
Biochemistry; 2000 Aug; 39(31):9077-83. PubMed ID: 10924100
[TBL] [Abstract][Full Text] [Related]
15. Identifying the bicyclomycin binding domain through biochemical analysis of antibiotic-resistant rho proteins.
Magyar A; Zhang X; Abdi F; Kohn H; Widger WR
J Biol Chem; 1999 Mar; 274(11):7316-24. PubMed ID: 10066795
[TBL] [Abstract][Full Text] [Related]
16. Bicyclomycin fluorescent probes: synthesis and biochemical, biophysical, and biological properties.
Brogan AP; Widger WR; Kohn H
J Org Chem; 2003 Jul; 68(14):5575-87. PubMed ID: 12839449
[TBL] [Abstract][Full Text] [Related]
17. A Large Insertion Domain in the Rho Factor From a Low G + C, Gram-negative Bacterium is Critical for RNA Binding and Transcription Termination Activity.
Simon I; Delaleau M; Schwartz A; Boudvillain M
J Mol Biol; 2021 Jul; 433(15):167060. PubMed ID: 34023400
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of a comprehensive set of bicyclomycin-resistant mutants.
Moyse KA; Knight JS; Richardson JP
Biochim Biophys Acta; 2001 Sep; 1520(3):223-33. PubMed ID: 11566358
[TBL] [Abstract][Full Text] [Related]
19. A new inhibitor of the transcription-termination factor Rho.
Carrano L; Alifano P; Corti E; Bucci C; Donadio S
Biochem Biophys Res Commun; 2003 Mar; 302(2):219-25. PubMed ID: 12604334
[TBL] [Abstract][Full Text] [Related]
20. Bicyclomycin sensitivity and resistance affect Rho factor-mediated transcription termination in the tna operon of Escherichia coli.
Yanofsky C; Horn V
J Bacteriol; 1995 Aug; 177(15):4451-6. PubMed ID: 7543478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
